TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05449002

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Practicing the Opposite (PTO)
Description: This 30-45-minute digital program is designed to help youths on the waitlist feel better prior to treatment and may also improve their treatment engagement and outcomes.

Intervention type: OTHER
Group type: OTHER
Intervention: Usual Clinical Care
Description: Usual care provided by participating youth mental health clinics in the United States.
Study: NCT05461547

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lung Ultrasound
Description: LUS will be performed and interpreted in real-time to guide acute management.
Study: NCT04995341

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: retinal photographs
Description: retinal photographs with a commercial portable bedside widefield fundus camera system
Study: NCT05461547

Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: Usual care to decide diagnosis and treatment
Study: NCT06442592

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Assessment of neurodevelopment (CA)
Description: The children will be seen by a neuropsychologist, who will then determine whether or not they have neurodevelopmental disorders.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Assessment of neurodevelopment (Nantes)
Description: The children will be seen by a multidisciplinary team (including a neuropsychologist), who will then determine whether or not they have neurodevelopmental disorders.

Intervention type: OTHER
Group type: OTHER
Intervention: Assessment of the parental stress
Description: Parents' parental stress will be assessed using the Parental Stress Index (PSI) questionnaire.

Intervention type: OTHER
Group type: OTHER
Intervention: Assessment of the parental stress
Description: Parents' parental stress will be assessed using the Parental Stress Index (PSI) questionnaire.
Study: NCT05774912

Intervention type: OTHER
Intervention: Ultrasound evaluation
Description: Fetal ultrasound evaluation will be collected longitudinally during the prenatal period from the weeks 14 every 4-5 weeks, for a total of maximum 6 ultrasound scans
Study: NCT05345327

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: SGLT2 inhibitor

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: Metformin
Study: NCT05657106

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Harm reduction kiosk
Description: The intervention involves enhancing an existing staffed harm reduction program (syringe service program) located in a local health department with a Kentucky Outreach Service Kiosk (KyOSK).
Study: NCT04963608

Intervention type: DRUG
Intervention: Inetetamab
Description: 8mg/kg iv day 1 followed by 6mg/kg iv day 1, cycled every 21 days
Study: NCT06316674

Intervention type: BEHAVIORAL
Intervention: sixth finger illusion
Description: Participants will undertake the sixth finger illusion that is a body illusion which elicits the presence of an extra numerary finger due to visuo-tactile stimulation.

Intervention type: BEHAVIORAL
Intervention: sixth finger illusion
Description: Participants will undertake the sixth finger illusion that is a body illusion which elicits the presence of an extra numerary finger due to visuo-tactile stimulation.
Study: NCT04858425

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Niclosamide
Description: Niclosamide tablets 400 mg 3 times daily for 14 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo tablets 400 mg 3 times daily for 14 days
Study: NCT06239688

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: essentiALZ
Description: essentiALZ is a web-based training that contains three hours of self-paced content separated into five modules, plus a final review. Modules include: 1) Alzheimer's disease and dementia; 2) person-centered care; 3) assessment and care planning; 4) activities of daily living; and 5) behaviors and communication. Staff will be encouraged to take the training over the course of four weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: essentiALZ
Description: essentiALZ is a web-based training that contains three hours of self-paced content separated into five modules, plus a final review. Modules include: 1) Alzheimer's disease and dementia; 2) person-centered care; 3) assessment and care planning; 4) activities of daily living; and 5) behaviors and communication. Staff will be encouraged to take the training over the course of four weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Project ECHO
Description: ECHO is a virtual tele-mentoring model grounded in case-based learning. It includes six weekly one-hour sessions of didactic and discussive learning. The first five sessions will reflect the content of the five essentiALZ modules, and the final session will address maintenance. ECHO sessions are group sessions that will be conducted via Zoom.
Study: NCT06369506

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: GTmeasurement
Description: GT was measured from the point corresponding to the base of the gingival sulcus and 1 mm and 2 mm apical to this point. If the GT was ≤1 mm, it was considered a thin phenotype, and if it was \>1 mm, it was considered a thick phenotype.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: GTmeasurement
Description: GT was measured from the point corresponding to the base of the gingival sulcus and 1 mm and 2 mm apical to this point. If the GT was ≤1 mm, it was considered a thin phenotype, and if it was \>1 mm, it was considered a thick phenotype.
Study: NCT05785806

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Skin to skin contact and co-parenting theory course
Description: On the day before delivery, pregnant women and their husbands attend a course on the theory of skin contact and co-parenting to explain the role and importance of skin contact ; to understand the knowledge of co-parenting and parenting care ; to learn the communication method and future parenting plan based on the theory of co-parenting, and to learn the operation of skin contact with newborns after delivery.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Skin to skin contact instruction manual and co-parenting theory brochure
Description: According to reading and analyzing the literature on skin contact, summarize the content of skin contact operation guidance ; read and analyze the relevant literature of co-parenting theory, and summarize the theoretical knowledge and practical operation methods of co-parenting. Pregnant women and their spouses can check in time.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Daily face-to-face skin to skin contact guidance during hospitalization
Description: After delivery, face-to-face skin-to-skin contact guidance and co-parenting communication and practice were given to the parturient and her husband on a daily basis during hospitalization. Establish a daily fixed skin contact duration target, and the specific operation is freely allocated by both parents.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online punching skin to skin contact
Description: Share common parenting related knowledge, daily skin contact reminders, emphasize mutual recognition and mutual support of parents, and conduct WeChat follow-up every two weeks to understand the physical and mental status of both parties and the growth of infants.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Routine obstetric care
Description: Routine prenatal training and postpartum education, including basic breastfeeding guidelines, touching, etc.
Study: NCT06507618

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen, Letrozole, Anastrozole, or Exemestane
Description: Choice and dose of neoadjuvant endocrine therapy at the discretion of the treating medical oncologist.
Study: NCT06501898

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: CoreBiome
Description: 300 mg, once daily of tributyrin for 4 weeks
Study: NCT04925661

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Roxadustat
Description: Roxadustat will be administered after fasting .

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Either dose of placebo will be administered after fasting .
Study: NCT06501898

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 300 mg, once daily of placebo for 4 weeks
Study: NCT06563908

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lipiodol® uterine treatment prior to IVF/ICSI
Description: Lipiodol®, treatment will be performed by a HSG technique with X-ray screening on day 3 or day 5 after oocyte retrieval. The contrast medium will be Lipiodol Ultra Fluide® (Guerbet, France), an iodized poppy seed oil obtained by substitution of ethyl esters for the glyceryl esters of Lipiodol®. One millilitre of Lipiodol Ultra Fluide® contains 0.48g iodine. Women will lie in the left lateral or supine position. Radiologists will use a 'no touch' technique after applying antiseptic solution to the cervix. Uterine cannulation using the Cook HSG catheter will be applied to conduct Lipiodol® treatment. Prewarmed (37oC) Lipiodol® will be slowly instilled, with intermittent fluoroscopic X-ray guidance. Up to 10 ml of Lipiodol® will be slowly injected into the uterus and directly monitored by fluoroscopy. If intravasation was observed on X-ray (contrast apparent in the venous system), instillation will be stopped immediately.
Study: NCT06029790

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: gum chewing
Description: For the patients in the experimental group, sugar-free xylitol gum containing 1.2-1.37 grams of xylitol per piece, available in the market, will be used. Participants in the experimental group will start chewing gum on the first postoperative day and will be allowed to chew a single piece of gum 3 times a day at 9:00, 14:00 and 19:00, respectively, for 15 minutes. The gum will be given to the participants regularly by a researcher until the first reported flatulence.
Study: NCT06467968

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cardiac ECG-gated PET imaging will added
Description: Blood sample will be used to measure troponin, BNP and CRP . After 68Ga-DOTATOC PET/CT whole body recording, a cardiac ECG-gated PET imaging will added
Study: NCT05866081

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard of care stent placement
Description: Participants will have a stent placed per randomization assigned if there are no complications (per protocol) during ureteroscopy that excludes the participant.

Intervention type: OTHER
Group type: OTHER
Intervention: No stent placement
Description: Participants not have a stent placed per randomization assigned if there are no complications (per protocol) during ureteroscopy that excludes the participant.
Study: NCT05478278

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: The psilocybin used in this study is synthetically manufactured in a laboratory and meets quality specifications suitable for human research use. The active drug is encapsulated using a hydroxypropyl methylcellulose (HPMC) capsule and contains psilocybin (API only in a capsule).
Study: NCT05866081

Intervention type: OTHER
Group type: OTHER
Intervention: Surveys
Description: All participants in the trial cohort and observational arms will be asked to complete survey instruments (evaluating their pain, quality of life, and experiences following ureteroscopy, as well as surveys evaluating their opinions and preferences around ureteral stenting, etc.).~Participants will also have routine clinical data (preoperative, perioperative, and postoperative) to be collected and analyzed for research purposes.

Intervention type: OTHER
Group type: OTHER
Intervention: Surveys
Description: All participants in the trial cohort and observational arms will be asked to complete survey instruments (evaluating their pain, quality of life, and experiences following ureteroscopy, as well as surveys evaluating their opinions and preferences around ureteral stenting, etc.).~Participants will also have routine clinical data (preoperative, perioperative, and postoperative) to be collected and analyzed for research purposes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Surveys
Description: All participants in the trial cohort and observational arms will be asked to complete survey instruments (evaluating their pain, quality of life, and experiences following ureteroscopy, as well as surveys evaluating their opinions and preferences around ureteral stenting, etc.).~Participants will also have routine clinical data (preoperative, perioperative, and postoperative) to be collected and analyzed for research purposes.
Study: NCT05511454

Intervention type: OTHER
Group type: OTHER
Intervention: Salivary and crevicular samples
Description: The samples will be taken from patients in both groups who meet the selection criteria during consultations at the Montpellier University Hospital's Odontology Department. During these consultations, a sample will be taken after rinsing the oral cavity with a glass of water. The samples will be taken before the periodontal assessment in order to avoid bleeding.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Salivary and crevicular samples
Description: The samples will be taken from patients in both groups who meet the selection criteria during consultations at the Montpellier University Hospital's Odontology Department. During these consultations, a sample will be taken after rinsing the oral cavity with a glass of water. The samples will be taken before the periodontal assessment in order to avoid bleeding.
Study: NCT05969730

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 MG
Description: In visit 1 which will be scheduled after the washout period, demographic information and baseline assessment will be conducted and patients will randomize into arms, baricitinib 4-mg daily plus fluocinolone 0.025% topical ointment and daily emollient of urea 10% topical cream (Arm A). Six weeks after visit 1, Visit 2 will be set to follow up on the patient condition, particularly in terms of adverse effects, and reorder their intervention. Visit 3 will be 12 weeks after visit 1 to perform the final assessment.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azathioprine 1.5-2.5 mg/kg
Description: In visit 1 which will be scheduled after the washout period, demographic information and baseline assessment will be conducted and patients will randomize into arms, azathioprine 1.5-2.5 mg/kg plus fluocinolone 0.025% topical ointment and daily emollient of urea 10% topical cream (Arm B). Six weeks after visit 1, Visit 2 will be set to follow up on the patient condition, particularly in terms of adverse effects, and reorder their intervention. Visit 3 will be 12 weeks after visit 1 to perform the final assessment.
Study: NCT05478278

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: The psilocybin used in this study is synthetically manufactured in a laboratory and meets quality specifications suitable for human research use. The active drug is encapsulated using a hydroxypropyl methylcellulose (HPMC) capsule and contains psilocybin (API only in a capsule).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: The psilocybin used in this study is synthetically manufactured in a laboratory and meets quality specifications suitable for human research use. The active drug is encapsulated using a hydroxypropyl methylcellulose (HPMC) capsule and contains psilocybin (API only in a capsule).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: The psilocybin used in this study is synthetically manufactured in a laboratory and meets quality specifications suitable for human research use. The active drug is encapsulated using a hydroxypropyl methylcellulose (HPMC) capsule and contains psilocybin (API only in a capsule).
Study: NCT04729296

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Golimumab
Description: For participants ≥45 kg, 50 mg of golimumab will be administered subcutaneously For participants \<45 kg, the dose of golimumab is 30 mg/m2 to maximum of 50 mg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Inactive Drug
Study: NCT05478278

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moxifloxacin
Description: The positive comparator used in this study is a 400 mg moxifloxacin tablet.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Micro-Crystalline Cellulose
Description: The placebo used in this study is encapsulated using a HPMC capsule and contains micro-crystalline cellulose.
Study: NCT06296680

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reiki
Description: The patients in the intervention group received Reiki to the seven chakra regions and additional areas with pain for a total duration of 25-30 minutes for four consecutive days. On the 4th day, pain and anxiety levels of the patients were evaluated after the last applications. On the 21st day, pain and anxiety levels were evaluated, State Anxiety Scale and Perceived Stress Scale were administered, and serum cortisol level was evaluated in the morning before the start of chemotherapy. At the 3rd month follow-up, pain and anxiety levels, state anxiety scale and perceived stress scale were evaluated.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Reiki
Description: The patients in the placebo group received Sham Reiki to the seven chakra regions for a total duration of 25-30 minutes for four consecutive days. On the 4th day, pain and anxiety levels of the patients were evaluated after the last applications. On the 21st day, pain and anxiety levels were evaluated, State Anxiety Scale and Perceived Stress Scale were administered, and serum cortisol level was evaluated in the morning before the start of chemotherapy. At the 3rd month follow-up, pain and anxiety levels, state anxiety scale and perceived stress scale were evaluated.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Progressive Relaxation Exercise
Description: PRE group patients received PRE for four consecutive days. On the 4th day, pain and anxiety levels of the patients were evaluated after the last applications. On the 21st day, pain and anxiety levels were evaluated, State Anxiety Scale and Perceived Stress Scale were administered, and serum cortisol level was evaluated in the morning before the start of chemotherapy. At the 3rd month follow-up, pain and anxiety levels, state anxiety scale and perceived stress scale were evaluated.
Study: NCT05632393

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daridorexant
Description: Daridorexant will be available as film-coated tablets for oral administration formulated at a strength of 50 mg.
Study: NCT06052592

Intervention type: OTHER
Intervention: Milk
Description: Newborns will be fed with breast milk, formula milk or postbiotic formula milk

Intervention type: OTHER
Intervention: Milk
Description: Newborns will be fed with breast milk, formula milk or postbiotic formula milk

Intervention type: OTHER
Intervention: Milk
Description: Newborns will be fed with breast milk, formula milk or postbiotic formula milk
Study: NCT06571435

Intervention type: DIAGNOSTIC_TEST
Intervention: Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST), and Posterior Shoulder Endurance Test
Description: The modified closed kinetic chain upper extremity stability test is reliable and is performed in an individualized manner by placing the hands on the floor at shoulder level. The evaluation process is the same as the original test; the total number of touches in 15 seconds is noted by lifting one hand, touching the other and placing it back. A total of 3 measurements are taken with a 45-second rest interval. The endurance capacity of the muscle group is an important factor for sports performance as it requires specific sports movements repeated in a certain period of time.~For posterior shoulder endurance test participants will lie with their face down. While the shoulder is hanging from the stretcher, individuals will be asked to lift the dumble calculated with the weight appropriate for their weight to 90 degrees abduction in accordance with the 60 bpm metronome. Their duration in seconds will be noted. 1 measurement will be made with each arm.

Intervention type: DIAGNOSTIC_TEST
Intervention: Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST), and Posterior Shoulder Endurance Test
Description: The modified closed kinetic chain upper extremity stability test is reliable and is performed in an individualized manner by placing the hands on the floor at shoulder level. The evaluation process is the same as the original test; the total number of touches in 15 seconds is noted by lifting one hand, touching the other and placing it back. A total of 3 measurements are taken with a 45-second rest interval. The endurance capacity of the muscle group is an important factor for sports performance as it requires specific sports movements repeated in a certain period of time.~For posterior shoulder endurance test participants will lie with their face down. While the shoulder is hanging from the stretcher, individuals will be asked to lift the dumble calculated with the weight appropriate for their weight to 90 degrees abduction in accordance with the 60 bpm metronome. Their duration in seconds will be noted. 1 measurement will be made with each arm.
Study: NCT05126303

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RMC-035
Description: Concentrate for Solution for Infusion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Concentrate for Solution for Infusion
Study: NCT04723719

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SIESTA
Description: SIESTA is a CBT sleep training for adolescents with ADHD with a focus on sleep hygiene, motivational interviewing and planning and organization.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment as usual for ADHD
Description: Participants continue their treatment as usual for ADHD.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual for ADHD
Description: Participants continue their treatment as usual for ADHD.